AI assistant
Sending…
WEST PHARMACEUTICAL SERVICES INC — Director's Dealing 2013
Aug 16, 2013
30339_dirs_2013-08-16_1fb3b69c-42c2-45b2-8f2a-4ba367f29e3e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2013-08-14
Reporting Person: Lennartz Heino (President Europe)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2013-08-14 | Common Stock | M | 2500.0000 | — | Acquired | 13687.8593 | Direct |
| 2013-08-14 | Common Stock | F | 1679.0000 | $78.7500 | Disposed | 12008.8593 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2013-08-14 | Stock Option (Right to Buy) | $ | M | 2500.0000 | Disposed | 2019-07-17 | Common Stock (2500.0000) | Direct |
Footnotes
F1: Unit price is $32.58.
F2: Conversion price is $32.58
More from WEST PHARMACEUTICAL SERVICES INC
Board/Management Information
2026
Jun 1
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 13
Regulatory Filings
2026
May 11
Declaration of Voting Results & Voting Rights Announcements
2026
May 5
Major Shareholding Notification
2026
Apr 30
Major Shareholding Notification
2026
Apr 29
Interim / Quarterly Report
2026
Apr 23
Earnings Release
2026
Apr 23
Major Shareholding Notification
2026
Mar 27